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Abstract
Background: The mechanisms during the initial phase of oxygen toxicity leading to pulmonary tissue
damage are incompletely known. Increase of tumour necrosis factor alpha (TNFalpha) represents one of
the first pulmonary responses to hyperoxia. We hypothesised that, in the initial phase of hyperoxia,
TNFalpha activates the caspase cascade in type II pneumocytes (TIIcells).
Methods: Lung sections or freshly isolated TIIcells of control and hyperoxic treated rats (48 hrs) were
used for the determination of TNFalpha (ELISA), TNF-receptor 1 (Western blot) and activity of caspases
8, 3, and 9 (colorimetrically). NF-kappaB activation was determined by EMSA, by increase of the p65
subunit in the nuclear fraction, and by immunocytochemistry using a monoclonal anti-NF-kappaB-antibody
which selectively stained the activated, nuclear form of NF-kappa B. Apoptotic markers in lung tissue
sections (TUNEL) and in TIIcells (cell death detection ELISA, Bax, Bcl-2, mitochondrial membrane
potential, and late and early apoptotic cells) were measured using commercially available kits.
Results: In vivo, hyperoxia activated NF-kappaB and increased the expression of TNFalpha, TNF-receptor
1 and the activity of caspase 8 and 3 in freshly isolated TIIcells. Intratracheal application of anti-TNFalpha
antibodies prevented the increase of TNFRI and of caspase 3 activity. Under hyperoxia, there was neither
a significant change of cytosolic cytochrome C or of caspase 9 activity, nor an increase in apoptosis of
TIIcells. Hyperoxia-induced activation of caspase 3 gradually decreased over two days of normoxia without
increasing apoptosis. Therefore, activation of caspase 3 is a temporary effect in sublethal hyperoxia and
did not mark the "point of no return" in TIIcells.
Conclusion: In the initiation phase of pulmonary oxygen toxicity, an increase of TNFalpha and its
receptor TNFR1 leads to the activation of caspase 8 and 3 in TIIcells. Together with the hyperoxic induced
increase of Bax and the decrease of the mitochondrial membrane potential, activation of caspase 3 can be
seen as sensitisation for apoptosis. Eliminating the TNFalpha effect in vivo by anti-TNFalpha antibodies
prevents the pro-apoptotic sensitisation of TIIcells.
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Background
Oxidative stress is an important factor of acute lung
injury. Prolonged exposure to high concentrations of oxy-
gen (hyperoxia) during mechanical ventilation represents
a life-saving intervention for critically ill patients. How-
ever, it also induces oxidative stress to the lung. The devel-
opment of therapeutic strategies, aiming to prevent lung
injury depends on a better understanding of the underly-
ing pathways of hyperoxia-induced pulmonary damage.
Severe, long lasting hyperoxia causes an inflammatory
reaction with an influx of inflammatory cells, cell prolifer-
ation and hypertrophy, an increase of cytokines, apoptotic
activity and subsequent morphologic evidence of lung
injury [1]. The first 24 to 48 hrs of oxygen exposure con-
stitute the initiation phase of the pulmonary oxygen tox-
icity [1]. Even though no morphologic injury has been
described during this phase, several changes occur due to
the hyperoxic exposure. Highly reactive oxygen species are
likely to cause lipid peroxidation, protein and DNA mod-
ification that will further cell injury [2,3]. On the other
hand, antioxidant enzymes are also induced and may
counteract the oxidative stress [4-6]. Perkowski et al. ana-
lysed more then 8700 genes during the early response (0
up to 48 hrs) to hyperoxia in total lung of mice. Out of
385 genes in the lung, 175 showed an increased and 210
a decreased expression [6]. These results indicate that the
initiation phase of hyperoxic-induced lung injury already
marks a very complex process that is still poorly under-
stood. From previous investigations it may be concluded
that in response to oxidative stress, the number of
endothelial cells strongly decreases in the post-initiation
phase, whereas epithelial cells seem to be relative resistant
to oxidative stress [1,7]. In contrast, it has also been
shown that in response to hyperoxic ventilation [8],
emphysema [9], activation of the Fas/FasL system [10],
exposure to donors of nitric oxide or hydrogen peroxide
[11], hyperoxia and nitric oxide [12], respiratory distress
syndrome [13], and hyperoxia-mediated increase of total
lung p53 protein expression [14] alveolar type II cells (TII-
cells) are severely damaged, culminating in apoptotic
death. TIIcells are functionally highly important epithelial
lung cells. They are responsible for the metabolism of
alveolar surfactant, serve as progenitor cells of type I pneu-
mocytes, and take part in the inflammatory response of
the lung [15-17]. Thus, damage and apoptotic elimina-
tion of TIIcells will severely alter pulmonary function.
Following the concept that hyperoxic lung injury is a con-
tinuous process, we assumed that appropriate metabolic
changes of TIIcells start during the initiation phase. This
would then, in response to longer lasting severe hyperoxia
or an additional stress, merge in apoptosis in the post-ini-
tiation phase [18]. Factors which induce such pro-apop-
totic sensitisation of TIIcells in the initiation phase are yet
unknown.
Elevation of tumour necrosis factor α (TNFα) represents
one of the first pulmonary responses to hyperoxia. Pre-
treatment of animals with antibodies directed against
TNFα reduces hyperoxia-induced lung injury, strongly
suggesting a causal relationship between TNFα and hyper-
oxic lung [19]. TNFα is a classic regulator of cell death by
apoptosis or necrosis [20,21]. Cellular response to TNFα
is mediated by TNF receptor type I and type II (TNFRI and
TNFRII; [22]). Pryhuber et al. [23] studied the contribu-
tion of both, TNFRI and TNFRII to hyperoxia-induced
lung injury and found that the average length of early sur-
vival under hyperoxic conditions is significantly
improved in mice that lack the TNFRI (-/-), when com-
pared with wild type or TNFRII (-/-) mice, respectively.
However, the blockade of the TNFα receptor function
does not protect against pulmonary inflammation and
toxicity induced by prolonged hyperoxia [23]. In fact, dur-
ing prolonged hyperoxia severe lung injury is most likely
initiated by additional factors beside TNFα, as the inhibi-
tion of TNF receptors does not further affect oxygen-
induced mortality [23]. Thus, TNFα and signal transduc-
tion via TNFRI seems to be responsible for metabolic
changes that regulate the length of survival under short
term hyperoxia.
In this paper, we tested the hypothesis that TNFα activates
caspases in the initiation phase of pulmonary oxygen tox-
icity in TIIcells without a significant increase in apoptosis.
Since apoptosis is modulated by cell-matrix and cell-cell
interactions in cultured TIIcells isolated from animals
with acute lung injury [24,25]. we used freshly isolated
TIIcells for our study.
Materials and methods
Hyperoxia
Wistar rats (body wt 120 g), each in an individual plastic
chamber were continuously gassed with 100 % oxygen for
48 hours. Water and food was available ad libitum. Prepa-
ration of the bronchoalveolar lavage, alveolar macro-
phages and TIIcells was carried out as previously described
[26].
Immunohistochemistry
Immunohistochemistry and microscopy were carried out
as previously described [26]. The following antibodies
were used: Rabbit polyclonal anti-rat TNFα antibody from
Biosource Europe (Nivelles, Belgium), rabbit polyclonal
anti TNFRI antibody raised against a recombinant peptide
(amino acids 30–301) including the extracellular domain
of TNFRI (Santa Cruz Biotechnology, Heidelberg, Ger-
many), and anti-active caspase 3 polyclonal antibody was
from Promega (Mannheim, Germany). SecondaryRespiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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antibodies conjugated with Alexa 499 and Alexa 594 were
from Molecular Probes Europe BV (Leiden, Netherlands).
Lung tissue sections were labelled with specific antibodies
directed against TNFRI, TNFα, caspase 3, and p180 [27],
an integral lamellar body-limiting membrane protein
(clone 3C9, Covance/Berkeley Antibody, Richmond, CA,
USA).
For double staining, the labelled preparations were ana-
lysed using a confocal laser scanning microscope (CLSM,
Leica Microsystems AG, Wetzlar, Germany), equipped
with an argon/krypton laser. Images were taken using a 40
× NA 1.3 oil objective to fluorescent excitation and emis-
sion spectra for Alexa 488 (excitation 490 nm, emission
520 nm) and for Alexa 594 (excitation 541 nm, emission
572 nm). With the dual-channel system of the confocal
microscope, dual-emission (535/590 nm) images were
recorded simultaneously with a scanning speed at 16 s/
frame (512 lines). Images were obtained and processed
using TCS NT Version 1.5.451 (Leica Microsystems AG,
Wetzlar, Germany). As controls, the tissue slides were
incubated with the Alexa-labelled second antibodies only.
No unspecific binding of the second antibodies occurred
(results not shown).
For threefold staining (Figure 6), fixed lung tissue and
freshly isolated TIIcells were incubated in 0.01 M phos-
phate buffered saline containing 1% (w/v) BSA and 0.3%
(w/v) Triton X-100 for 1 hr at room temperature (RT).
Detection of lamellar bodies and active Caspase 3 was
achieved by incubation with mab 3C9 (20 hrs at 4°C) fol-
lowed by Alexa 488-labelled goat anti-mouse IgG (2 hrs at
RT) and with anti-active caspase 3 followed by Alexa 594-
labelled goat anti-rabbit IgG (2 hrs at RT), respectively.
Nuclear DNA was stained with 4',6-diamidino-2-phe-
nylindole (DAPI; Molecular Probes Europe BV, Leiden,
Netherlands) for 20 minutes at RT.
Laser scanning confocal microscopy was performed using
a ZEISS LSM 510 system with Axiovert microscope (Carl
Zeiss Jena GmbH, Jena, Germany) with 40×/1.3 Oil Dic or
63×/1.4 Oil Dic objective, equipped with an argon,
helium/neon and violet laser set to 488, 543 and 405 nm,
respectively. The multitrack standard FITC/Rhodamine/
DAPI configuration was selected.
Determination of apoptosis in lung tissue
TUNEL reaction
Sections of rat lung were prepared as described [26]. After
deparaffinization and proteinase K-treatment, apoptotic
cuts of chromatin DNA were specifically detected by nick
end labelling of 3'-OH DNA ends with fluorescein-dUTP
using terminal deoxynucleotidyl transferase. (MEBSTAIN
Apoptosis Kit Direct, MBL, Naka-ku Nagoya, Japan). Sec-
tions were analyzed using a confocal laser scanning
microscope as described above for double staining.
Determination of apoptosis in freshly isolated TIIcells
Cell Death Detection ELISA
Cytoplasmic histone-DNA fragments were quantified
using the Cell Death Detection ELISA (Roche, Mannheim,
Germany).
Flow cytometry
We used the TACS™ Annexin V-FITC Detection kit (R&D
Systems, Wiesbaden, Germany) to quantify the popula-
tion of early and late apoptotic cells in percent of total
cells. The tests were performed according to the protocols
of the manufactures.
Determination of caspase activities
Activities of caspases 3, 8 and 9 were determined in the
lysates of 8 × 106 TIIcells for each group and for each cas-
pase with the Colorimetric assays from R&D Systems Inc.
(Wiesbaden, Germany). When the pro-caspases had to be
determined, an aliquot of the lysate (corresponding to 2 ×
106 cells) was preincubated with 0.1 µg granzyme (Calbi-
ochem, Bad Soden, Germany; dissolved in 5 µl 0.9%
NaCl) for 30 min at 37°C.
Determination of NF-κB activation
Immunocytochemistry
Activation of NF-κB was measured by immunocytochem-
istry using a monoclonal anti-NF-κB-antibody
(MAB3026, Chemicon International, Temecula, USA),
that recognises an epitope which includes the nuclear
location signal of p65, the DNA binding subunit mainly
responsible for the strong gene-inductory potential of NF-
κB. Thus, only the activated form of NF-κB was measured.
The semiquantitative estimation of NF-κB subunit by con-
focal microscopy was carried out as recently described in
detail [28].
Immunoblotting
Translocation of NF-κB to the nucleus was assessed as
described by Li et al. by immunoblotting of nuclear
extracts using a rabbit polyclonal antibody (biomol
GmbH, Hamburg, Germany) directed against the p65-
subunit [29].
Electrophoretic mobility shift assay
(EMSA) was employed to detect the activated transcrip-
tion factor NF-κB. Because this method is based on the
binding of the transcription factors to their specific DNA
recognition sequences, it is highly specific. Labelling of
the NF-κB consensus oligonucleotide and handling of the
assay were as described by the manufacturer (Gel Shift
Assay Systems, Promega GmbH, Mannheim, Germany).
Briefly, 50 micrograms of TIIcell nuclear extract wereRespiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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preincubated in reaction buffer for 10 minutes at RT. A
[32P]-labelled oligonucleotide (Promega GmbH, Man-
nheim, Germany) which contains DNA binding sites for
NF-κB transcription factors was then added to the reaction
Hyperoxia activates caspase 3 in TIIcells Figure 6
Hyperoxia activates caspase 3 in TIIcells. Rats were kept normoxic (control) or subjected to hyperoxia. Lung sections (A) and 
freshly isolated TIIcells (B) were immunohistochemically threefold stained as described in Materials and Methods. Cell nuclei 
stained light blue (DAPI). TIIcells are distinguishable by the close proximity of their nuclei to green stained lamellar bodies (A; 
arrows). Active caspase 3 appears red labelled and is predominantly found in the cytosol of TIIcells upon hyperoxic treatment 
of rats (A and B). Bar 10 µm;Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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mixture and incubated for 20 minutes at RT. The com-
plexes were separated on a 4% polyacrylamide gel that
was dried and exposed to autoradiography. The specificity
of the DNA-binding protein for the putative binding site
was established by competition experiments using unla-
belled NF-κB consensus oligonucleotide.
Intratracheal application of anti-TNFα antibodies
Wistar rats were lightly anaesthetised by inhalation of
ether. The rats obtained intratracheally 50 µg goat IgG
(PERBIO SCIENCE, Bonn, Germany) or 50 µg goat poly-
clonal anti-rat TNFα antibody (Santa Cruz Biotechnology,
Heidelberg, Germany) per animal, respectively. Thereafter
the rats were kept at hyperoxic conditions as described in
hyperoxia. After 48 hrs, the TIIcells were isolated and
TNFRI expression and caspase-3 activity were determined
as described above.
Other methods
For the determination of the TNFα concentration in TII-
cells, macrophages, plasma or cell-free bronchoalveolar
lavage, we used a commercially available ELISA kit from
Biosource (Ratingen, Germany). The determination of
different apoptotic markers [18], Western blot analysis
[17], mRNA isolation and Real-time quantitative PCR
reaction for the determination of the expression of
mRNAs in TIIcells was described in detail previously [26].
GSH, GSSG and GSH-reductase were determined by
HPLC with subsequent fluorescence detection as previ-
ously described [17].
Statistical analysis
Differences between two groups were assessed using the
Student's t-test. Probability values < 0.05 (two-tailed)
were considered significant (see legends of Tables and
Figures).
Results
Hyperoxia-induced changes in lung tissue
To test the general usefulness of our hypothesis, we first
characterised the oxygen-induced changes in lung-tissue-
sections. Immunohistochemically, we observed a clear
increase in TNFα, TNFRI, and caspase 3 activities in lung
tissue of hyperoxic rats in relation to normoxic animals in
the initiation phase (Figure 1). Albeit the increase of these
pro-apoptotic parameters in lung tissue corroborated our
hypothesis, this approach does not allow to identify the
participating cell types. Furthermore, we tested lung sec-
tions for DNA-degradation products using the TUNEL
reaction (Figure 2). Here, TIIcells are distinguishable from
other cells of the lung by their content of lamellar bodies.
Lamellar bodies were immunohistochemically labelled in
lung sections with an antibody directed against the 180-
kDa lamellar body-limiting membrane protein (red, Fig-
ure 2). Upon hyperoxia, we found sporadically a fragmen-
tation of DNA (green, Figure 2), but no co-localisation of
the 180-kDa lamellar body-limiting membrane protein
and DNA-fragments. The intensity of red lamellar body
stain increased in lung sections from hyperoxic rats. This
is in good accordance with previously published electron
micrographs showing swollen and deformed lamellar
bodies after hyperoxia [30]. From these results, we con-
clude in agreement with the literature [1,7,25]. that suble-
thal hyperoxia of rats did not induce apoptosis in TIIcells
in vivo; at least not in the initiation phase.
The results indicate that apoptotic parameters as are TNFα
content, TNFRI expression and caspase-3 activity increase
in lung tissue during the initiation phase but do not
induce TIIcell apoptosis in vivo. Following our hypothesis,
we examined whether TIIcells undergo oxidative stress at
our conditions, and whether an increase of TNFα, TNFRI
expression, and caspase-3 activity appears in isolated
TIIcells.
Hyperoxia-induced oxidative stress of freshly isolated 
TIIcells
The determination of cellular GSH, oxidised GSH (GSSG),
and the activity of the GSH-reductase showed the oxida-
tive burdening of TIIcells. In response to hyperoxia, the
GSSG content significantly increased and the GSH reduct-
ase activity significantly decreased (Table 1). The GSH
content in freshly isolated TIIcells has rarely been deter-
mined. In our TIIcell population, the GSH content differs
in relation to previously published data of freshly isolated
TIIcells from rat [31] and rabbit [32] by the factor of about
2 and 4, respectively. These differences might be explained
by different methods of TIIcell isolation and by species
specificity.
The ratio GSH/(GSH+GSSG) is one of the most sensitive
parameters to describe oxidative burdening. Our values
are comparable to the values found by van Klaveren et al.
in freshly isolated type II cells (0.816 versus 0.815) [30].
This ratio decreased in response to hyperoxia in vitro to
0.74 [31] and in our in vivo approach to 0.61 (Table 1).
With respect to the published data, we conclude that our
treatment induced oxidative burdening in freshly isolated
type II cells.
Hyperoxia activates NF-κB
NF-κB activation has been described as an indicator of
oxidative stress [33,34]. In response to sublethal hyper-
oxia, the content of activated NF-κB in TIIcells clearly
increased (Figure 3A). The picture shows that the larger
portion of activated NF-κB seems to be localised in
cytosol. The semiquantitative determination of activated
NF-κB showed a significant increase (control: 12.7 ± 9.0;
hyperoxia: 59.5 ± 11.6; n = 12; p < 0.01) in the nucleus of
TIIcells in response to hyperoxia. In the cytosol, there wasRespiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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also an increase of activated NF-κB (1.6-fold), however,
this difference curtly fails the level of significance.
Additionally, we detected a translocation of the NF-κB-
subunit p65 into the nuclear protein fraction as estimated
by Western blot analysis (Figure 3B). Hyperoxia increased
the content of the p65-subunit in the nuclear protein frac-
tion of TIIcells 1.68-fold (SD 0.58, n = 4) compared to
normoxic control, but the difference did not reach signif-
icance. Whether the immunoreactive band above the p65-
subunit in the Western blot of the hyperoxic group is non-
specific or a possible post-translational modification can
not be decided. In Figure 3C we confirm the hyperoxia
induced activation of NF-κB by EMSA of the nuclear pro-
tein fractions of TIIcells freshly isolated from control
(lanes 1, 2) and hyperoxic (lanes 3, 4) rats. Addition of
unlabelled specific oligonucleotide clearly competes with
the [32P]-labelled probe confirming the specificity of the
bands.
Hyperoxia increases the expression of TNFRI, TNFα and caspase 3 in vivo Figure 1
Hyperoxia increases the expression of TNFRI, TNFα and caspase 3 in vivo. Lung sections of normoxic (control) and hyperoxic 
rats were prepared as described in Materials and Methods and were labelled by single immunofluorescence with antibodies 
directed against TNFRI, TNFα or active caspase 3Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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Hyperoxia increases synthesis and secretion of TNFα by 
TIIcells
The concentration of TNFα significantly increased in
response to hyperoxia of rats in plasma, alveolar fluid,
lung macrophages and TIIcells (Table 2) as determined by
ELISA. Flow cytometric analysis of the TNFα content in
freshly isolated TIIcell preparations from control and
hyperoxic rats confirmed the increase of the TNFα concen-
tration in macrophages and TIIcells. In response to hyper-
oxia, TNFα increased in TIIcells 1.45-fold and in
macrophages 1.87-fold compared to control. In TIIcells,
TNFα seems to be localised in lamellar bodies (Figure 4),
whereas cytoplasmic caspase 3 showed no co-localisation
with lamellar bodies as expected. The latter result attaches
value to the histochemically detected localisation of TNFα
No significant apoptosis was found in TIIcells upon hyperoxia in vivo for 48 hrs Figure 2
No significant apoptosis was found in TIIcells upon hyperoxia in vivo for 48 hrs. Lung tissue of normoxic rats (left) and of 
hyperoxic rats (right) were tested for DNA fragmentation by TUNEL reaction as described in Materials and Methods. The pos-
itive TUNEL reaction is represented by green fluorescence. The presence of lamellar bodies is indicated by red fluorescence. 
Pseudo-colour blue was used to highlight the contours of lung tissue. Bar: 25 µm.
Table 1: Effect of hyperoxia on GSH reductase activity, and on GSH and GSSG content in TIIcells
Control Hyperoxia
GSH reductase (% of control) 100 76 ± 10*
GSH (µmol/mg protein) 0.022 ± 0.015 0.020 ± 0.008
GSSG (µmol/mg protein) 0.005 ± 0.0015 0.013 ± 0.001*
GSH/(GSH+GSSG) (ratio) 0.81 0.61
Activity of glutathione (GSH) reductase and concentration of GSH and GSSG were determined in freshly prepared TIIcells of rats exposed to air 
(control) or oxygen for 48 hrs (hyperoxia) as described in Materials and Methods. Values are means ± standard deviation of n = 3 independent 
experiments. Asterisk indicates a significant difference to control (p < 0.05).Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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Activation of NF-κB in TIIcells and its enrichment in the nuclear protein fraction after hyperoxic treatment of rats Figure 3
Activation of NF-κB in TIIcells and its enrichment in the nuclear protein fraction after hyperoxic treatment of rats. Freshly iso-
lated TIIcells from normoxic (control) and hyperoxic rats were prepared for immunocytochemistry, SDS-PAGE and immunob-
lotting as described in Materials and Methods. A, activation of NF-κB was measured by immunocytochemistry using a 
monoclonal anti-NF-κB-antibody overlapping the nuclear localisation signal of the p65 subunit in the NF-κB heterodimer. Acti-
vated NF-κB in the nucleus and cytosol was quantified as described recently in detail [28]. The signal of activated NF-κB in the 
nucleus increased 4.7 fold in respose to hyperoxia (n = 12; p < 0.05). Bar: 10 µm. B, the nuclear protein fraction [52] of TIIcells 
was subjected to SDS-PAGE and immunoblotting. The p65 subunit of NF-κB was visualised using a rabbit polyclonal antibody, 
and its expression was densitometrically estimated. Values of n = 4 independent experiments are given as mean ± SD in arbi-
trary units (control = 1). C, Electrophoretic mobility shift assay for NF-κB in freshly isolated TIIcells from normoxic (lanes 1, 2) 
and hyperoxic (lanes 3, 4) rats. Signal competition upon addition of unlabelled oligonucleotide (lanes 2, 4).Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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Table 2: Effect of hyperoxia on the TNFα content in different specimen from rat
Control Hyperoxia
Plasma (pg/ml) 106 ± 31 149 ± 11
Macrophages (ng/mg protein) 11.4 ± 3.7 19.4 ± 2.8*
TIIcells (ng/mg protein; n = 6) 18.5 ± 2.1 27.2 ± 6.7*
Bronchoalveolar lavage (pg/ml) 109 ± 1 172 ± 38*
Spontaneous secretion of TNFα by TIIcells (ng 
× mg cell protein-1 × hr-1)
6.3 ± 1.3 21.2 ± 7.5*
Concentration of TNFα was determined in plasma, macrophages, TIIcells and bronchoalveolar lavage of rats exposed to air (control) or oxygen for 
48 hrs (hyperoxia) by ELISA as described in Materials and Methods. Spontaneous secretion of TNFα was measured in cell-free supernatant upon 
incubation of freshly isolated TIIcells in DMEM for 30 min at 37°C. TNFα concentrations are given as means with standard deviation of n = 3 
independent experiments unless stated otherwise. Asterisk indicates a significant difference to control (p < 0.05).
TNFα is localised in lamellar bodies and caspase 3 in the cytosol of TIIcells Figure 4
TNFα is localised in lamellar bodies and caspase 3 in the cytosol of TIIcells. After hyperoxia, rat lungs were fixed and the sec-
tions were immunohistochemically double labelled as described in Materials and Methods. A: bar 50 µm; B: higher magnification 
of the indicated area of A (arrow); bar 10 µm. By confocal microscopy, TIIcells were identified by the green labelling of lamellar 
bodies (see Methods). The red labelled TNFα appears yellow (arrow in B) when co-localised in lamellar bodies as shown in 
two TIIcells in B.Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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in lamellar bodies, because it is unlikely an artefact. The
spontaneous secretion of TNFα by TIIcells significantly
increased in response to hyperoxia (Table 2).
Hyperoxia induces the expression of TNFRI and activates 
caspases in TIIcells
Hyperoxia induced an significant increase of TNFRI on
TIIcells (4.9-fold ± 2.7, n = 6), whereas the expression of
Fas, a member of the same receptor family, did not change
(Figure 5). TNFRI-mediated action of TNFα depends on
the so called "death domain" representing a part of the
intracellular segment of the receptor protein responsible
for the activation of pro-caspase 8. Caspase 8 in turn can
activate pro-caspase 3, a feature previously reviewed [35-
37]. We show in situ that the activation of caspase 3 actu-
ally occurs in TIIcells and that caspase activation as a
response to an unspecific stress, e.g. isolation, can be
excluded (Figure 6). This staining technique excepts cyto-
plasm and membranes, thus, cells can hardly be delim-
ited. However, TIIcells are identifiable by the immediate
proximity of their nuclei to lamellar bodies (green).
As shown in Table 3, in TIIcells the activity of caspase 8
and 3 increased in response to hyperoxia, whereas the
activity of caspase 9 did not change. Pre-incubation with
granzyme activated pro-caspases and resulted in an
increase of caspase 8 and -3 activities in control and
hyperoxic TIIcells (Table 4). However, the activation in
control cells clearly exceed that in hyperoxic TIIcells, indi-
cating that pro-caspases were already, at least in part, acti-
vated in response to hyperoxia.
Anti-TNFα in vivo prevents hyperoxia-driven increase in 
TNFRI and in active caspase 3
In order to demonstrate the causality between hyperoxia
and TNFRI-mediated activation of caspases, we attempted
to bind TNFα by anti-TNFα antibodies. Table 5 shows that
a single intratracheal application of anti-TNFα antibodies
immediately preceding hyperoxic treatment prevents the
hyperoxic-induced increase of TNFRI expression and cas-
pase-3 activity in freshly isolated TIIcells. These results
indicate that both TNFRI expression and caspase-3 activa-
tion were induced by TNFα. This corroborates the concept
that in a cascade starting by the TNFα/TNFRI-interaction
caspase 8 is activated which in turn activates caspase 3.
Hyperoxia upregulates genes of TNFRI, TNFα and 
caspases 3 and 8
The content of individual mRNAs in TIIcells was deter-
mined by Real-time PCR. In agreement with microarray
analysis in total lung of mice [6] we found that the
amount of GAPDH mRNA did not change in the first 48
hrs of hyperoxia (results not shown). Therefore, GAPDH
was used as a house keeping gene. In contrast, Ho et al.
found a small but significant increase of GAPDH mRNA
in lung tissue [5]. This difference may be caused by differ-
ent base material (TIIcells versus lung tissue) and method-
ical differences (Taqman versus densitometry of
autoradiographs).
In response to sublethal hyperoxia the mRNA content of
TNFα, TNFRI and caspases increased (Table 6). The incre-
ment of caspase-8 mRNA was not significant, but even a
∆∆ct  of -1.15 indicates a 2.2-fold increase of mRNA
content.
Hyperoxia of rats does not induce apoptosis in freshly 
isolated TIIcells
As mentioned above in this section, no increase of apop-
tosis was detected in TIIcells in response to sublethal
hyperoxia by immunohistochemistry (Figure 2). To con-
firm this result, we analyzed biochemical parameters of
apoptosis in freshly isolated TIIcells. In agreement with
our immunohistochemical results, sublethal hyperoxia of
rats did not increase apoptosis in freshly isolated TIIcells
(Table 7). Hyperoxia was without effect on anti-apoptotic
Bcl-2, and cytosolic cytochrome C, although the pro-
apoptotic Bax increased and the mitochondrial
transmembrane potential slightly decreased (Table 7). In
accordance with these results, the activity of caspase 9 did
not change. Therefore, activation of caspase 3 seems to be
catalysed by caspase 8.
Hyperoxia of rats followed by normoxia reduced caspase 
3 activity but did not increase apoptosis in TIIcells
After hyperoxia for 48 hrs, we detected an activation of
caspase 8 and caspase 3. Much to our surprise, we found
no increase in apoptosis of TIIcells although the activity of
these caspases increased. However, apoptosis might occur
later than 48 hrs and will not necessarily arise concomi-
tantly with caspase activation. Thus, following hyperoxia
the animals were kept for 24 and 48 hrs under normoxic
conditions to test TIIcells for appearance of apoptosis at a
later time point.
During normoxia, caspase 3 activity gradually decreases
compared to control, whereas apoptosis did not change
significantly as detected by cell death detection ELISA and
by the number of early and late apoptotic cells (Table 8).
Discussion
Short-time hyperoxia, as used in this experiments repre-
sents the initiation phase of lung injury [1]. We started our
investigations with the aim to characterise metabolic
changes in TIIcells taking place in this phase. On the one
hand, these changes should be less complex than in post-
initiation phases. On the other hand, therapeutic inter-
ventions to avoid or minimise hyperoxia-induced lung
injury should focus in particular on this phase, becauseRespiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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Hyperoxia increases the expression of TNFRI but not of Fas in TIIcells Figure 5
Hyperoxia increases the expression of TNFRI but not of Fas in TIIcells. For the expression analysis of TNFRI and Fas the mem-
brane fraction of freshly isolated TIIcells was prepared. TNFRI (A) and Fas (B) were visualised by Western blot technique, and 
their expression was densitometrically determined. Values of n = 6 independent experiments are given as means ± SD in arbi-
trary units (control = 1). Asterisk indicates a significant difference to control (p < 0.05).Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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Table 3: Effect of hyperoxia on the activity of caspases in TIIcells
Control Hyperoxia
Caspase 8 (n = 6) 100 143 ± 14*
Caspase 3 (n = 6) 100 168 ± 23*
Caspase 9 (n = 3) 100 108 ± 11
Caspase activity in freshly prepared TIIcells of rats exposed to air (control) or oxygen for 48 hrs (hyperoxia) was determined colorimetrically as 
described in Materials and Methods. Values are means ± S.D. given in arbitrary units (control = 100). Asterisk indicates a significant difference to 
control (p < 0.05).
Table 4: Effect of granzyme-treatment on the activity of caspases in TIIcells from normoxic and hyperoxic rats
Control Hyperoxia
Granzyme -+-+
Caspase 8 100 155 ± 7* 100 110 ± 4*
Caspase 3 100 216 ± 14* 100 155 ± 10*
Caspase activity in freshly prepared TIIcells of rats exposed to air (control) or oxygen for 48 hrs (hyperoxia) was determined colorimetrically as 
described in Materials and Methods. In some experiments, cell lysates were incubated in the presence of granzyme prior to determination of caspase 
activity (see Methods). Values are means ± s. d. given in arbitrary units (values without granzyme = 100) of n = 3 independent experiments. Asterisk 
indicates a significant difference between granzyme-treated and untreated samples (p < 0.05).
Table 5: Effect of intratracheal application of anti-TNFα antibodies on hyperoxic induced parameters of TIIcells
Hyperoxia
without with anti-TNFα antibody
TNFRI 100 26 ± 19*
Caspase 3 activity 100 64 ± 5*
Rats obtained intratracheal 50 µg goat-IgG (without) or 50 µg goat polyclonal anti-TNFα antibodies (with anti-TNFα antibody) preceding hyperoxic 
treatment. Hyperoxia of rats was carried out as described in Material and Methods. Values are means ± SD of n = 3 independent experiments given 
in percent (hyperoxia without anti-TNFα antibody = 100). Determination of TNFRI (Western blot) and of caspase 3 activity (colorimetrically) was 
as described in Material and Methods.). Asterisk indicates a significant difference compared to control (p < 0.05).
Table 6: Effect of hyperoxia on the mRNA content of TNFα, TNFRI, and caspases in TIIcells
number of cycles (∆ct) increase of mRNA
Control Hyperoxia ∆∆ct -fold
TNFα 3.66 ± 0.66 0.93 ± 0.30* -2.73 6.6
TNFRI 5.02 ± 0.19 4.44 ± 0.11* -0.58 1.5
Caspase 8 10.3 ± 0.89 9.15 ± 0.35 -1.15 2.2
Caspase 3 5.33 ± 0.25 4.29 ± 0.48* -1.04 2.1
The mRNA of three animals per group was isolated and combined. The content of specific mRNA was determined using Real time-PCR. In parallel, 
GAPDH was determined in each run as internal standard. The values are given as number of GAPDH-corrected cycle (∆ct) ± SD of n = 3 
determinations. ∆∆ct is the difference of the number of cycles between control and hyperoxia; a decrease of ∆ct indicates an increase of the mRNA, 
also given as a factor of increase. Asterisk indicates a significant difference to control (p < 0.05).Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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morphologic injury of lung tissue, inflammation, and
death of lung cells originate from here. Furthermore, the
metabolic changes in the initiation phase may, at least in
part, be still reversible.
For the first time, we show that sublethal hyperoxia causes
not only an increase in TNFα concentration in lung tissue
(as previously published [38,39]), but also in freshly iso-
lated TIIcells and that this increase is combined with an
enhanced expression of TNFRI and an activation of cas-
pase 3.
It has been widely assumed that macrophages are the
source of TNFα in alveolar fluid [40]. Our findings
provide evidence that hyperoxic treatment of rats pro-
vokes a rise in cellular TNFα not only in alveolar
macrophages [41]. We show that the TNFα-gene is up-reg-
ulated in TIIcells; in parallel, the TNFα-protein content
increased. To the best of our knowledge, our data suggests
for the first time that TNFα is localised in lamellar bodies.
In the light of this assumption, the secretion of TNFα as a
constituent of the lamellar bodies by TIIcells might repre-
sent a significant contribution to the increased TNFα-con-
tent in alveolar fluid. Whether the small increase of the
TNFα concentration in plasma observed by us indicates a
beginning systemic inflammation or rather reflects a
transfer of TNFα from the alveolar space to plasma,
remains open (Table 2).
Cellular effects of TNFα are mediated mainly by its spe-
cific receptor, TNFRI. In agreement with our hypothesis,
the expression of TNFRI in TIIcells is up-regulated on
mRNA and protein level in response to sublethal hyper-
oxia, while the Fas-expression did not change, although
both receptors belong to the same family (Figure 5). It
may be speculated that a parallel increase of effector and
specific receptor always occurs when the cellular metabo-
lism in TIIcells can be affected by an autocrine
mechanism. The increase of Fas/Fas-Ligand might be char-
acteristic in post-initiation phases.
The intracellular part of the transmembrane TNFRI pro-
tein contains the "death domain" which is responsible for
the activation of caspase 8. This can trigger the path to the
final part of apoptosis via activation of caspase 3 [36]. In
line with this, we found enhanced levels of caspases 8 and
3, yet caspase 9 was not activated. The latter result is cor-
roborated by the absence of an increased mitochondrial
cytochrome C release. The data presented here demon-
strate that sublethal hyperoxia of rats did not induce
Table 7: Effect of hyperoxia on apoptotic parameters in TIIcells
Control Hyperoxia
Bcl-2 (n = 5) 100 96 ± 8
Bax (n = 5) 100 134 ± 28*
Cytochrome c (n = 5) 100 102 ± 15
Mitochondrial membrane potential 100 81 ± 8*
Early apoptotic TIIcells 100 101 ± 26
Late apoptotic TIIcells 100 94 ± 22
Cell death detection ELISA 100 104 ± 13
Several apoptotic parameters were determined in freshly prepared TIIcells of rats exposed to air (control) or oxygen for 48 hrs (hyperoxia) as 
described in Materials and Methods. Values are means ± S.D. given in arbitrary units (control = 100) of n = 3 independent experiments unless stated 
otherwise. Asterisk indicates a significant difference to control (p < 0.05).
Table 8: Apoptotic parameters upon sublethal hyperoxia of rats followed by normoxia
Hyperoxia followed by normoxia for
48 hrs hyperoxia 24 hrs normoxia 48 hrs normoxia
Caspase 3 activity 171 ± 18* 97 ± 16 73 ± 29
Early apoptotic cells 102 ± 13 95 ± 14 109 ± 26
Late apoptotic cells 106 ± 29 125 ± 25 85 ± 17
Cell death detection ELISA 97 ± 23 104 ± 6 95 ± 14
Activity of caspase 3 and parameters of apoptosis detected in freshly prepared TIIcells of rats exposed to oxygen for 48 hrs (hyperoxia) followed by 
normoxia for 24 or 48 hrs as described in Materials and Methods. Values are means ± S.D. given in arbitrary units (normoxic control = 100) of n = 
3 independent experiments. Asterisk indicates a significant difference compared to control (p < 0.05)Respiratory Research 2005, 6:10 http://respiratory-research.com/content/6/1/10
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apoptosis in TIIcells despite of the increase in TNFα con-
tent, TNFRI expression, and activation of caspase 3.
To check whether this pro-apoptotic state in TIIcells is
indeed triggered by TNFα and whether it may be reversi-
ble, anti-TNFα antibodies were administered intratrache-
ally prior to hyperoxic exposure. We show that this
treatment completely prevented hyperoxic-induced
increase of TNFRI expression and caspase 3 activation.
It is a widely accepted concept that activation of caspase 3
marks the "point of no return" in the pathway of
apoptotic death of mammalian cells. However, we found
that neither in lung tissue nor in freshly isolated TIIcells
apoptosis occurs in response to sublethal hyperoxia
despite the significant activation of caspases 8 and 3. In
other words, the increase of caspase 8 and 3 in response to
sublethal hyperoxia did not mark the "point of no return"
in TIIcells. This interpretation of our results is strongly
corroborated by Perfettini and Kroemer [37]. They sum-
marised that caspase inhibition does not avoid but actu-
ally encourage death in TNF induced shock, indicating
that caspase activation is not basically synonymous with
apoptotic cell death. It could be argued that no apoptosis
was found in freshly isolated TIIcells because the increase
of caspase 3 activity and the increase of apoptotic param-
eters does not occur concomitantly. However, we found
no increase in apoptosis of TIIcells in a normoxic period
of 24 and 48 hrs directly succeeding the hyperoxic treat-
ment of animals, whereas the caspase 3 activity gradually
decreased. These results indicate that caspase 3 activation
in response to sublethal hyperoxia is reversible and does
not kill TIIcells essentially.
The reason why the activation of caspases did not induce
apoptosis of TIIcells is not clear. On the one hand, activa-
tion of NF-κB has often been implicated as an anti-apop-
totic event [42-45], and TNFα induces also the expression
of anti-apoptotic TNFα-receptor-associated-factors in
lung cells and might inhibit by this way TNFα-induced
cell death or apoptosis [46]. Therefore, it may be assumed
that both NF-κB activation and expression of anti-apop-
totic TNFα-receptor-associated-factors arrest the hyper-
oxia-induced metabolic changes of TIIcells in the pro-
apoptotic state. On the other hand, it can not be excluded
that the extend of caspase 3 activation (1.68-fold com-
pared to control) is not high enough to induce apoptosis
of TIIcells although a 1.8-fold increase of caspase 3 is com-
bined with apoptosis in total lung of a hyperoxia/pneu-
monia model [47]. We hypothesise that caspase 3
activation is then followed by apoptosis, when its activa-
tion occurs via strong mitochondrial damage resulting in
cytochrome c release and caspase 9 activation in post-ini-
tiation phases of pulmonary oxygen toxicity. This concept
is supported by recent findings that mitochondrial cyto-
chrome c release is a key event in hyperoxia-induced lung
injury [48]. In fact, the mitochondrial membrane poten-
tial and Bax significantly changed in TIIcells in the
initiation phase of hyperoxic lung injury, but without
cytochrome c release or activation of caspase 9.
Recently, it has been shown that in response to severe
hyperoxia of mice apoptosis and necrosis contribute to an
extensive cell death; p53, bax, bcl-x, and Fas increased in
mRNA and protein level, but the activity of caspase 3 and
caspase 1 did not change [49]. This independence of
apoptosis from caspase activities in the lung has also been
shown in freshly isolated TIIcells. Previously, we showed
that an increase of TIIcell-apoptosis in response to
vitamin E deficiency of rats is independent of caspase acti-
vation [18]. Furthermore, using p53-deficient and Fas-
null mice, Barazzone et al. [49] showed that Fas and p53
activation exhibits no linkage to lung injury in response to
severe hyperoxia of mice. Contrariwise, it has also been
shown that Fas activation in vitro [50] and in vivo results
in TIIcell apoptosis and lung inflammation [10,51]. These
results confirm that hyperoxic-induced lung injury is mul-
tifactorial, and that the elimination of one factor in the
network of factors activated in the post-initiation phases
often can not avoid lung injury in response to severe
hyperoxia.
In summary, TIIcells were not killed in the initiation
phase of pulmonary oxygen toxicity. More precisely, its
pro-apoptotic sensitisation is the background that,
together with an additional stress factor, hyperoxia causes
lung injury probably by apoptotic elimination of TIIcells.
In agreement with this idea, we showed that the combina-
tion of the stress factors hyperoxia and vitamin E defi-
ciency increases TIIcell apoptosis [18]. Taking into
account that premature neonates exhibit vitamin E defi-
ciency, it is consequential that ventilation of premature
neonates suffering from respiratory distress syndrome
with high levels of inspired oxygen amplifies lung injury,
which is associated with TIIcell apoptosis [13].
Conclusions
In the initiation phase of pulmonary oxygen toxicity, an
increase of TNFalpha and its receptor TNFR1 leads to the
activation of caspase 8 and 3 in TIIcells. Together with the
hyperoxic induced increase of Bax and the decrease of the
mitochondrial membrane potential, activation of caspase
3 can be seen as sensitisation for apoptosis. Eliminating
the TNFα effect in vivo by anti-TNFα antibodies prevents
the pro-apoptotic sensitisation of TIIcells.
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